Free Trial

Public Sector Pension Investment Board Boosts Stake in Astrana Health, Inc. $ASTH

Astrana Health logo with Medical background

Public Sector Pension Investment Board raised its stake in Astrana Health, Inc. (NASDAQ:ASTH - Free Report) by 27.3% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 131,811 shares of the company's stock after purchasing an additional 28,276 shares during the period. Public Sector Pension Investment Board owned about 0.24% of Astrana Health worth $4,087,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds and other institutional investors have also made changes to their positions in the business. Vanguard Group Inc. raised its position in shares of Astrana Health by 4.5% during the 1st quarter. Vanguard Group Inc. now owns 4,898,992 shares of the company's stock worth $151,918,000 after acquiring an additional 213,033 shares in the last quarter. Dimensional Fund Advisors LP raised its position in shares of Astrana Health by 10.7% during the 4th quarter. Dimensional Fund Advisors LP now owns 1,045,540 shares of the company's stock worth $32,968,000 after acquiring an additional 101,192 shares in the last quarter. 325 Capital LLC raised its position in shares of Astrana Health by 30.3% during the 4th quarter. 325 Capital LLC now owns 886,916 shares of the company's stock worth $27,964,000 after acquiring an additional 206,009 shares in the last quarter. SteelPeak Wealth LLC increased its position in Astrana Health by 4.8% during the first quarter. SteelPeak Wealth LLC now owns 568,176 shares of the company's stock worth $17,619,000 after buying an additional 26,192 shares during the period. Finally, Charles Schwab Investment Management Inc. increased its position in Astrana Health by 6.0% during the first quarter. Charles Schwab Investment Management Inc. now owns 499,529 shares of the company's stock worth $15,490,000 after buying an additional 28,200 shares during the period. Institutional investors and hedge funds own 52.77% of the company's stock.

Astrana Health Stock Performance

ASTH traded up $0.7850 during trading on Friday, hitting $30.7550. 76,316 shares of the stock were exchanged, compared to its average volume of 338,279. The firm has a market capitalization of $1.72 billion, a P/E ratio of 60.29, a PEG ratio of 0.72 and a beta of 0.85. Astrana Health, Inc. has a 1-year low of $21.20 and a 1-year high of $63.20. The stock has a fifty day moving average price of $25.16 and a two-hundred day moving average price of $28.72. The company has a quick ratio of 1.59, a current ratio of 1.59 and a debt-to-equity ratio of 0.52.

Astrana Health (NASDAQ:ASTH - Get Free Report) last announced its earnings results on Thursday, August 7th. The company reported $0.19 earnings per share for the quarter, missing the consensus estimate of $0.36 by ($0.17). Astrana Health had a net margin of 1.04% and a return on equity of 3.43%. The company had revenue of $654.81 million during the quarter, compared to analysts' expectations of $639.13 million. During the same quarter last year, the business posted $0.40 earnings per share. The company's revenue for the quarter was up 34.7% compared to the same quarter last year. Astrana Health has set its Q3 2025 guidance at EPS. As a group, sell-side analysts predict that Astrana Health, Inc. will post 1.15 earnings per share for the current year.

Astrana Health Company Profile

(Free Report)

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.

Featured Articles

Institutional Ownership by Quarter for Astrana Health (NASDAQ:ASTH)

Should You Invest $1,000 in Astrana Health Right Now?

Before you consider Astrana Health, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Astrana Health wasn't on the list.

While Astrana Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Next Tech Boom: AI Robots Are Coming Sooner Than You Think!
Tech Stocks Stumble: Will Nvidia’s Report Spark a Rebound?
Follow the Money: 5 Stocks Institutions Are Buying NOW

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines